SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3mp6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 6	VAL A 746 VAL A 788 ILE A 798 ASN A1005	None	0.97A	1e06A-3mp6A: undetectable	1e06A-3mp6A: 15.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SN0_B_T44B602_1 (TRANSTHYRETIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 7	LYS A1015 GLU A1019 ALA A1014 ALA A 815	None	1.09A	1sn0B-3mp6A: undetectable 1sn0D-3mp6A: undetectable	1sn0B-3mp6A: 16.04 1sn0D-3mp6A: 16.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOH_C_FRDC305_2 (POL POLYPROTEIN PEPTIDE INHIBITOR)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 5	LEU A1000 GLY A1027 ALA A 847 ILE A 846	None	0.83A	2aohB-3mp6A: undetectable	2aohB-3mp6A: 10.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 11	ALA A1041 ILE A 846 VAL A 835 LEU A 814 ILE A 817	None	1.26A	2h42A-3mp6A: undetectable	2h42A-3mp6A: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	LEU A1000 ILE A 846 VAL A 835 LEU A 814 ILE A 817	None	0.95A	2h42C-3mp6A: undetectable	2h42C-3mp6A: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	ALA A1002 LEU A1018 PHE A1017 VAL A1031 GLY A 754	None	1.11A	2ve3A-3mp6A: undetectable	2ve3A-3mp6A: 23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZW9_A_SAMA801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 2)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 8	THR A 831 LEU A1023 ASP A1025 GLU A 849	None None None MAL A 600 (-2.9A)	1.00A	2zw9A-3mp6A: undetectable	2zw9A-3mp6A: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 6	PHE A 996 ALA A 900 LEU A 985 PRO A 897	None	0.95A	3bgdA-3mp6A: undetectable	3bgdA-3mp6A: 19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 7	VAL A 848 GLY A1038 PRO A 967 LYS A1043	None	0.75A	3bjwC-3mp6A: undetectable	3bjwC-3mp6A: 13.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D9L_A_ACTA501_0 (CTD-PEPTIDE RNA-BINDING PROTEIN 16)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 5	PRO A1121 PRO A1248 TYR A1195 TYR A1119	None	1.35A	3d9lA-3mp6A: undetectable 3d9lY-3mp6A: undetectable	3d9lA-3mp6A: 13.79 3d9lY-3mp6A: 2.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_A_BEZA302_0 (DISULFIDE INTERCHANGE PROTEIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 6	PRO A 864 LEU A 885 ALA A 961 PRO A 863	None	1.32A	3gv1A-3mp6A: undetectable 3gv1C-3mp6A: undetectable	3gv1A-3mp6A: 13.60 3gv1C-3mp6A: 13.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_B_BEZB301_0 (DISULFIDE INTERCHANGE PROTEIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 6	LEU A 885 ALA A 961 PRO A 863 PRO A 864	None	1.31A	3gv1A-3mp6A: undetectable 3gv1B-3mp6A: undetectable	3gv1A-3mp6A: 13.60 3gv1B-3mp6A: 13.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	10 / 12	ASP A 752 LYS A 753 LYS A 780 GLU A 782 GLU A 783 ALA A 801 ASP A 803 ARG A 804 GLU A 849 TYR A1079	MAL A 600 (-2.9A) MAL A 600 (-2.8A) None None None MAL A 600 (-3.4A) MAL A 600 (-2.8A) MAL A 600 (-3.9A) MAL A 600 (-2.9A) None	0.91A	3jyrA-3mp6A: 62.3	3jyrA-3mp6A: 63.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	11 / 12	ASP A 752 LYS A 753 LYS A 780 GLU A 782 GLU A 783 ALA A 801 ASP A 803 GLU A 849 PRO A 892 TRP A 968 TYR A1079	MAL A 600 (-2.9A) MAL A 600 (-2.8A) None None None MAL A 600 (-3.4A) MAL A 600 (-2.8A) MAL A 600 (-2.9A) MAL A 600 (-3.4A) MAL A 600 (-4.3A) None	0.60A	3jyrA-3mp6A: 62.3	3jyrA-3mp6A: 63.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	6 / 7	ASN A 750 TRP A 800 GLU A 891 TYR A 893 MET A1068 TRP A1078	MAL A 600 ( 4.7A) MAL A 600 (-4.3A) MAL A 600 (-3.8A) MAL A 600 (-3.8A) MAL A 600 ( 4.2A) MAL A 600 (-3.6A)	0.24A	3jyrA-3mp6A: 62.3	3jyrA-3mp6A: 63.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 11	GLN A1103 ALA A1102 ALA A 900 GLY A 904 ALA A 926	None	1.06A	3mg0V-3mp6A: undetectable 3mg0W-3mp6A: undetectable	3mg0V-3mp6A: 20.04 3mg0W-3mp6A: 18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	VAL A 934 LEU A 898 GLY A 925 ALA A 926 LEU A1099	None	0.99A	3n8yB-3mp6A: undetectable	3n8yB-3mp6A: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	PHE A 894 GLY A1038 LEU A1037 GLU A 849 ALA A 969	MAL A 600 (-4.8A) None None MAL A 600 (-2.9A) None	0.91A	3tbgB-3mp6A: undetectable	3tbgB-3mp6A: 21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	PHE A 894 GLY A1038 LEU A1037 GLU A 849 ALA A 969	MAL A 600 (-4.8A) None None MAL A 600 (-2.9A) None	0.89A	3tbgD-3mp6A: undetectable	3tbgD-3mp6A: 21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	ALA A 969 TYR A 755 TYR A 948 ASN A 972 GLY A 966	None	1.39A	3vwqA-3mp6A: undetectable	3vwqA-3mp6A: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 5	GLU A1046 ASP A1052 ASP A1025 ASN A1032	None	1.35A	3vywD-3mp6A: undetectable	3vywD-3mp6A: 21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKI_A_IMNA201_1 (TRANSTHYRETIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	3 / 3	LYS A 880 LEU A 877 ALA A 879	None	0.69A	4ikiA-3mp6A: undetectable	4ikiA-3mp6A: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 5	ASN A1005 ALA A 789 GLY A 794 ASP A 752	None None None MAL A 600 (-2.9A)	0.95A	4n48A-3mp6A: undetectable	4n48A-3mp6A: 22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 9	ALA A1002 ALA A 843 LEU A 841 LEU A1000 VAL A 999	None	1.13A	4or0B-3mp6A: undetectable	4or0B-3mp6A: 23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RJD_B_TFPB204_1 (CALMODULIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 8	LEU A1028 GLY A1027 GLU A1029 GLU A 760 ALA A 759	None	1.34A	4rjdA-3mp6A: undetectable 4rjdB-3mp6A: undetectable	4rjdA-3mp6A: 9.77 4rjdB-3mp6A: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	6 / 12	ALA A1080 ALA A1076 GLY A 904 ALA A 926 PHE A 907 VAL A 919	None	1.45A	5w4zA-3mp6A: undetectable	5w4zA-3mp6A: 9.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	6 / 12	ALA A1080 ALA A1076 GLY A 904 ALA A 926 PHE A 907 VAL A 919	None	1.48A	5w4zB-3mp6A: undetectable	5w4zB-3mp6A: 9.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X23_A_LSNA503_1 (CYTOCHROME P450 2C9)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 5	PRO A1197 GLY A1198 THR A1199 LYS A1200	None	1.11A	5x23A-3mp6A: undetectable	5x23A-3mp6A: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XXI_A_LSNA502_1 (CYTOCHROME P450 2C9)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	4 / 6	PRO A1197 GLY A1198 THR A1199 LYS A1200	None	1.05A	5xxiA-3mp6A: undetectable	5xxiA-3mp6A: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA603_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	3 / 3	TYR A 893 ASN A 965 LEU A 851	MAL A 600 (-3.8A) None None	0.80A	6b58A-3mp6A: undetectable	6b58A-3mp6A: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BM5_A_SAMA1301_0 (METHIONINE SYNTHASE)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 11	PRO A 871 GLU A 868 PRO A 992 ALA A 901 PRO A 897	None	1.41A	6bm5A-3mp6A: undetectable	6bm5A-3mp6A: 22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ECX_A_SAMA1301_0 (STIE PROTEIN)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	LEU A1013 GLY A 762 VAL A 773 LEU A 745 ILE A 747	None	1.01A	6ecxA-3mp6A: undetectable	6ecxA-3mp6A: 20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 12	GLN A1103 ALA A1102 ALA A 900 GLY A 904 ALA A 926	None	0.99A	6hwdH-3mp6A: undetectable 6hwdI-3mp6A: undetectable	6hwdH-3mp6A: 9.88 6hwdI-3mp6A: 10.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_V_BO2V301_0 (PROTEASOME SUBUNIT BETA TYPE-2)	3mp6	MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA- ASSOCIATED FACTOR 29 (Escherichia coli; Saccharomyces cerevisiae; unidentified)	5 / 11	GLN A1103 ALA A1102 ALA A 900 GLY A 904 ALA A 926	None	0.99A	6hwdV-3mp6A: undetectable	6hwdV-3mp6A: 9.88

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"VAL A 746;VAL A 788;ILE A 798;ASN A1005","None","0.97A","1e06A-3mp6A:undetectable","1e06A-3mp6A:15.34"],["1SN0_B_T44B602_1","TRANSTHYRETIN;TRANSTHYRETIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"LYS A1015;GLU A1019;ALA A1014;ALA A 815","None","1.09A","1sn0B-3mp6A:undetectable;1sn0D-3mp6A:undetectable","1sn0B-3mp6A:16.04;1sn0D-3mp6A:16.04"],["2AOH_C_FRDC305_2","POL POLYPROTEIN;PEPTIDE INHIBITOR","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"LEU A1000;GLY A1027;ALA A 847;ILE A 846","None","0.83A","2aohB-3mp6A:undetectable","2aohB-3mp6A:10.34"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"ALA A1041;ILE A 846;VAL A 835;LEU A 814;ILE A 817","None","1.26A","2h42A-3mp6A:undetectable","2h42A-3mp6A:21.10"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"LEU A1000;ILE A 846;VAL A 835;LEU A 814;ILE A 817","None","0.95A","2h42C-3mp6A:undetectable","2h42C-3mp6A:21.10"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"ALA A1002;LEU A1018;PHE A1017;VAL A1031;GLY A 754","None","1.11A","2ve3A-3mp6A:undetectable","2ve3A-3mp6A:23.16"],["2ZW9_A_SAMA801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 2","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"THR A 831;LEU A1023;ASP A1025;GLU A 849","None;None;None;MAL A 600 (-2.9A)","1.00A","2zw9A-3mp6A:undetectable","2zw9A-3mp6A:21.94"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"PHE A 996;ALA A 900;LEU A 985;PRO A 897","None","0.95A","3bgdA-3mp6A:undetectable","3bgdA-3mp6A:19.36"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"VAL A 848;GLY A1038;PRO A 967;LYS A1043","None","0.75A","3bjwC-3mp6A:undetectable","3bjwC-3mp6A:13.55"],["3D9L_A_ACTA501_0","CTD-PEPTIDE;RNA-BINDING PROTEIN 16","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"PRO A1121;PRO A1248;TYR A1195;TYR A1119","None","1.35A","3d9lA-3mp6A:undetectable;3d9lY-3mp6A:undetectable","3d9lA-3mp6A:13.79;3d9lY-3mp6A:2.54"],["3GV1_A_BEZA302_0","DISULFIDE INTERCHANGE PROTEIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"PRO A 864;LEU A 885;ALA A 961;PRO A 863","None","1.32A","3gv1A-3mp6A:undetectable;3gv1C-3mp6A:undetectable","3gv1A-3mp6A:13.60;3gv1C-3mp6A:13.60"],["3GV1_B_BEZB301_0","DISULFIDE INTERCHANGE PROTEIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"LEU A 885;ALA A 961;PRO A 863;PRO A 864","None","1.31A","3gv1A-3mp6A:undetectable;3gv1B-3mp6A:undetectable","3gv1A-3mp6A:13.60;3gv1B-3mp6A:13.60"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",10,"ASP A 752;LYS A 753;LYS A 780;GLU A 782;GLU A 783;ALA A 801;ASP A 803;ARG A 804;GLU A 849;TYR A1079","MAL A 600 (-2.9A);MAL A 600 (-2.8A);None;None;None;MAL A 600 (-3.4A);MAL A 600 (-2.8A);MAL A 600 (-3.9A);MAL A 600 (-2.9A);None","0.91A","3jyrA-3mp6A:62.3","3jyrA-3mp6A:63.44"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",11,"ASP A 752;LYS A 753;LYS A 780;GLU A 782;GLU A 783;ALA A 801;ASP A 803;GLU A 849;PRO A 892;TRP A 968;TYR A1079","MAL A 600 (-2.9A);MAL A 600 (-2.8A);None;None;None;MAL A 600 (-3.4A);MAL A 600 (-2.8A);MAL A 600 (-2.9A);MAL A 600 (-3.4A);MAL A 600 (-4.3A);None","0.60A","3jyrA-3mp6A:62.3","3jyrA-3mp6A:63.44"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",6,"ASN A 750;TRP A 800;GLU A 891;TYR A 893;MET A1068;TRP A1078","MAL A 600 ( 4.7A);MAL A 600 (-4.3A);MAL A 600 (-3.8A);MAL A 600 (-3.8A);MAL A 600 ( 4.2A);MAL A 600 (-3.6A)","0.24A","3jyrA-3mp6A:62.3","3jyrA-3mp6A:63.44"],["3MG0_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"GLN A1103;ALA A1102;ALA A 900;GLY A 904;ALA A 926","None","1.06A","3mg0V-3mp6A:undetectable;3mg0W-3mp6A:undetectable","3mg0V-3mp6A:20.04;3mg0W-3mp6A:18.13"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"VAL A 934;LEU A 898;GLY A 925;ALA A 926;LEU A1099","None","0.99A","3n8yB-3mp6A:undetectable","3n8yB-3mp6A:20.93"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"PHE A 894;GLY A1038;LEU A1037;GLU A 849;ALA A 969","MAL A 600 (-4.8A);None;None;MAL A 600 (-2.9A);None","0.91A","3tbgB-3mp6A:undetectable","3tbgB-3mp6A:21.73"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"PHE A 894;GLY A1038;LEU A1037;GLU A 849;ALA A 969","MAL A 600 (-4.8A);None;None;MAL A 600 (-2.9A);None","0.89A","3tbgD-3mp6A:undetectable","3tbgD-3mp6A:21.73"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"ALA A 969;TYR A 755;TYR A 948;ASN A 972;GLY A 966","None","1.39A","3vwqA-3mp6A:undetectable","3vwqA-3mp6A:21.42"],["3VYW_D_SAMD401_1","MNMC2","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"GLU A1046;ASP A1052;ASP A1025;ASN A1032","None","1.35A","3vywD-3mp6A:undetectable","3vywD-3mp6A:21.86"],["4IKI_A_IMNA201_1","TRANSTHYRETIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",3,"LYS A 880;LEU A 877;ALA A 879","None","0.69A","4ikiA-3mp6A:undetectable","4ikiA-3mp6A:14.34"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"ASN A1005;ALA A 789;GLY A 794;ASP A 752","None;None;None;MAL A 600 (-2.9A)","0.95A","4n48A-3mp6A:undetectable","4n48A-3mp6A:22.16"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"ALA A1002;ALA A 843;LEU A 841;LEU A1000;VAL A 999","None","1.13A","4or0B-3mp6A:undetectable","4or0B-3mp6A:23.16"],["4RJD_B_TFPB204_1","CALMODULIN;CALMODULIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"LEU A1028;GLY A1027;GLU A1029;GLU A 760;ALA A 759","None","1.34A","4rjdA-3mp6A:undetectable;4rjdB-3mp6A:undetectable","4rjdA-3mp6A:9.77;4rjdB-3mp6A:9.77"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",6,"ALA A1080;ALA A1076;GLY A 904;ALA A 926;PHE A 907;VAL A 919","None","1.45A","5w4zA-3mp6A:undetectable","5w4zA-3mp6A:9.53"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",6,"ALA A1080;ALA A1076;GLY A 904;ALA A 926;PHE A 907;VAL A 919","None","1.48A","5w4zB-3mp6A:undetectable","5w4zB-3mp6A:9.53"],["5X23_A_LSNA503_1","CYTOCHROME P450 2C9","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"PRO A1197;GLY A1198;THR A1199;LYS A1200","None","1.11A","5x23A-3mp6A:undetectable","5x23A-3mp6A:21.42"],["5XXI_A_LSNA502_1","CYTOCHROME P450 2C9","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",4,"PRO A1197;GLY A1198;THR A1199;LYS A1200","None","1.05A","5xxiA-3mp6A:undetectable","5xxiA-3mp6A:21.23"],["6B58_A_ACTA603_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",3,"TYR A 893;ASN A 965;LEU A 851","MAL A 600 (-3.8A);None;None","0.80A","6b58A-3mp6A:undetectable","6b58A-3mp6A:22.35"],["6BM5_A_SAMA1301_0","METHIONINE SYNTHASE","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"PRO A 871;GLU A 868;PRO A 992;ALA A 901;PRO A 897","None","1.41A","6bm5A-3mp6A:undetectable","6bm5A-3mp6A:22.87"],["6ECX_A_SAMA1301_0","STIE PROTEIN","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"LEU A1013;GLY A 762;VAL A 773;LEU A 745;ILE A 747","None","1.01A","6ecxA-3mp6A:undetectable","6ecxA-3mp6A:20.53"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"GLN A1103;ALA A1102;ALA A 900;GLY A 904;ALA A 926","None","0.99A","6hwdH-3mp6A:undetectable;6hwdI-3mp6A:undetectable","6hwdH-3mp6A:9.88;6hwdI-3mp6A:10.87"],["6HWD_V_BO2V301_0","PROTEASOME SUBUNIT BETA TYPE-2","3mp6","MALTOSE-BINDING PERIPLASMIC PROTEIN,LINKER,SAGA-ASSOCIATED FACTOR 29","Escherichia coli;Saccharomyces cerevisiae;unidentified",5,"GLN A1103;ALA A1102;ALA A 900;GLY A 904;ALA A 926","None","0.99A","6hwdV-3mp6A:undetectable","6hwdV-3mp6A:9.88"]]